Acceder

Publicaciones - Metalofármacos antitumorales no convencionales

Cargando...
Kasparkova J, Novohradsky V, Ruiz J, Brabec V. Photoactivatable, mitochondria targeting dppz iridium(III) complex selectively interacts and damages mitochondrial DNA in cancer cells. Chem Biol Interact. 2024 Apr 1;392:110921. doi: 10.1016/j.cbi.2024.110921. Epub 2024 Feb 19. PubMed PMID: 38382705.
AÑO: 2024; IF: 5.1
38382705
Marco A, Ashoo P, Hernandez-Garcia S, Martinez-Rodriguez P, Cutillas N, Vollrath A, Jordan D, Janiak C, Gandia-Herrero F, Ruiz J. Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains. J Med Chem. 2024 Mar 7. doi: 10.1021/acs.jmedchem.3c01869. Online ahead of print. PubMed PMID: 38451016.
AÑO: 2024; IF: 7.3
38451016
Kasparkova J, Hernandez-Garcia A, Kostrhunova H, Goicuria M, Novohradsky V, Bautista D, Markova L, Santana MD, Brabec V, Ruiz J. Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis. J Med Chem. 2024 Jan 11;67(1):691-708. doi: 10.1021/acs.jmedchem.3c01978. Epub 2023 Dec 23. PubMed PMID: 38141031; PubMed Central PMCID: PMC10788912.
AÑO: 2024; IF: 7.3
38141031
Ballester FJ, Hernandez-Garcia A, Santana MD, Bautista D, Ashoo P, Ortega-Forte E, Barone G, Ruiz J. Photoactivatable Ruthenium Complexes Containing Minimal Straining Benzothiazolyl-1,2,3-triazole Chelators for Cancer Treatment. Inorg Chem. 2024 Apr 8;63(14):6202-6216. doi: 10.1021/acs.inorgchem.3c04432. Epub 2024 Feb 22. PubMed PMID: 38385171; PubMed Central PMCID: PMC11005040.
AÑO: 2024; IF: 4.6
38385171
Ortega-Forte E, Rovira A, Lopez-Corrales M, Hernandez-Garcia A, Ballester FJ, Izquierdo-Garcia E, Jorda-Redondo M, Bosch M, Nonell S, Santana MD, Ruiz J, Marchan V, Gasser G. A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions. Chem Sci. 2023 Jun 8;14(26):7170-7184. doi: 10.1039/d3sc01844j. eCollection 2023 Jul 5. PubMed PMID: 37416722; PubMed Central PMCID: PMC10321499.
AÑO: 2023; IF: 8.4
37416722
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

Metalofármacos antitumorales no convencionales